DEFB1 and colitis: Like pretreatment, post‐treatment of colitis mice with I3C suppressed colitis and colitis associated symptoms (Figures S6B–S6I, Supporting Information) and increased the expression of AhR and BD1 at both mRNA (Figure S6J, Supporting Information) and protein (Figure S6K, Supporting Information) levels.